Literature DB >> 11687683

Normal values for sincalide cholescintigraphy: comparison of two methods.

H A Ziessman1, L R Muenz, A K Agarwal, A A ZaZa.   

Abstract

PURPOSE: To establish normal gallbladder ejection fraction (GBEF) values for two sincalide (cholecystokinin [CCK]) infusion dose rates, 0.01 microg per kilogram of body weight infused for 3 minutes and 0.01 microg/kg infused for 60 minutes.
MATERIALS AND METHODS: Twenty healthy subjects were examined. GBEFs were calculated for the 3-minute infusion and for each 15-minute interval for the 60-minute infusion. Normal values were determined by using the mean +/- 2 SDs and a more rigorous statistical analysis.
RESULTS: With the 3-minute infusion, GBEFs were significantly more variable than with the 45- and 60-minute values for the 60-minute infusion (P < .01, .002). With intervals including 95% of the population, the GBEF lower normal range was 16.8% for the 3-minute infusion but 31% and 41% for the 45- and 60-minute values, respectively. GBEFs of less than 35% were noted in six (30%) of 20 healthy subjects with the 3-minute infusion but in only one with the 60-minute infusion. Hepatobiliary ultrasonography was performed in six of seven subjects with GBEF of 36% or less, and US findings in all six were normal.
CONCLUSION: A 3-minute infusion of sincalide, 0.01 microg/kg, produces too variable a GBEF response to establish a clinically useful normal range. With 0.01 microg/kg infused for 60 minutes, clinically useful normal values were established at 45 and 60 minutes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687683     DOI: 10.1148/radiol.2212010154

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  "Characterization of basal hepatic bile...".

Authors:  Harvey A Ziessman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

2.  Normokinetic biliary dyskinesia: a novel diagnosis.

Authors:  Christopher DuCoin; Robert Faber; Marlon Ilagan; William Ruderman; Daryl Wier
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

Review 3.  Controversies concerning pathophysiology and management of acalculous biliary-type abdominal pain.

Authors:  Amit Rastogi; Adam Slivka; Arthur James Moser; Arnold Wald
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 4.  Receptor function reserve: a new parameter for disease detection.

Authors:  H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12       Impact factor: 9.236

5.  Determination of the biliary excretion of piperacillin in humans using a novel method.

Authors:  Giulia Ghibellini; Lakshmi S Vasist; Terence E Hill; William D Heizer; Richard J Kowalsky; Kim L R Brouwer
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 6.  Cholecystectomy for biliary dyskinesia: how did we get there?

Authors:  Klaus Bielefeldt; Shreyas Saligram; Susan L Zickmund; Anwar Dudekula; Mojtaba Olyaee; Dhiraj Yadav
Journal:  Dig Dis Sci       Date:  2014-09-06       Impact factor: 3.199

7.  A novel method for the determination of biliary clearance in humans.

Authors:  Giulia Ghibellini; Brendan M Johnson; Richard J Kowalsky; William D Heizer; Kim L R Brouwer
Journal:  AAPS J       Date:  2004-11-23       Impact factor: 4.009

Review 8.  Gallbladder dyskinesia: fact or fiction?

Authors:  Geoffrey Francis; John Baillie
Journal:  Curr Gastroenterol Rep       Date:  2011-04

9.  HIDA scan ejection fraction does not predict sphincter of Oddi hypertension or clinical outcome in patients with suspected chronic acalculous cholecystitis.

Authors:  S B Young; M Arregui; K Singh
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

Review 10.  Methods to evaluate biliary excretion of drugs in humans: an updated review.

Authors:  Giulia Ghibellini; Elaine M Leslie; Kim L R Brouwer
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.